16 May

What Analysts Think of Home Depot ahead of Its Q1 Results

WRITTEN BY Rajiv Nanjapla

Analysts’ recommendations

Of the 34 analysts covering Home Depot (HD), 67.6% have given it “buy” recommendations, while 32.4% have given it “holds.” On average, analysts’ 12-month price target for Home Depot is $205.86, which represents a potential upside of 7.4% from its price of $191.76 on May 15.

On May 15, Oppenheimer raised its price target on HD from $200 to $215. Morgan Stanley raised its price target from $200 to $210 on April 15. On May 7, RBC lowered its price target from $223 to $217.

What Analysts Think of Home Depot ahead of Its Q1 Results

Peer comparison

Of the 32 analysts following Lowe’s Companies (LOW), 68.8% have given it “buy” recommendations, while 32.2% have given it “holds.” Analysts have given LOW a 12-month price target of $118.17, which implies a potential upside of 9.8% from its current price of $107.62.

Of the 25 analysts covering Williams-Sonoma (WSM), 4.0% have given it “buy” recommendations, while 76% have given it “holds,” and the remaining 20% are recommending “sells.” Analysts’ 12-month price target for WSM stands at $56.41, which represents a potential upside of 6.0% from its current price of $53.20.

Among the 22 analysts covering Bed Bath & Beyond (BBBY), 9.1% have given it “buy” recommendations, while 72.7% have given it “holds,” and 18.2% have given it “sells.” The average 12-month target price of $17.87 for BBBY implies a potential upside of 17.2% from its current price of $15.25.

Valuation multiple

On May 15, Home Depot was trading at a forward PE multiple of 18.5x compared to 16.8x at the beginning of the year. The rise of 11.6% in Home Depot stock since the beginning of the year has resulted in a rise in its valuation multiple. In comparison, its peers Lowe’s, WSM, and BBBY were trading at forward PE multiples of 17.0x, 11.4x, and 7.6x, respectively.

Strong same-store sales growth and higher margins have allowed Home Depot to trade at a higher forward PE multiple than its peers.

Latest articles

On October 17, Cannabis 2.0 legalized edibles, beverages, and concentrates in Canada. As the country waits for the benefits, is Cannabis 3.0 next?

Prohibition Partners expects that by 2024, the legal cannabis market could reach $103.9 billion and the medical cannabis market could reach $62.6 billion.

The cannabis sector was trading in the red today. MKM Partners lowered its revenue estimates for Canopy Growth (CGC) (WEED) and Aurora Cannabis (ACB).

Ford plans to unveil its crossover SUV, the Mach-E, on November 17. Ford committed $11.5 billion toward the electrification of its fleet through 2022.

This week is important for the cannabis sector, as Canopy Growth and Aurora Cannabis are both set to report their earnings results on November 14.

Currently, 33 states and Washington, D.C., have legalized medical cannabis, but it's illegal in Kansas. Even having a small amount is considered a crime.